CoChat

Chronic Granulomatous Disease: a Comprehensive Review

Yu, Hsin-Hui, Yang, Yao-Hsu, Chiang, Bor-Luen · 2021 · Clinical Reviews in Allergy & Immunology

The DOI matches its Crossref record; 101 of the 102 references it cites were found in a registry or an index.

Abstract

Chronic granulomatous disease (CGD) is a primary immunodeficiency of phagocyte function due to defective NADPH oxidase (phox). Compared with the common types of CYBB/gp91 phox, NCF1/p47 phox, and CYBA/p22 phox deficiency, NCF4/p40 phox deficiency is a mild and atypical form of CGD without invasive bacterial or fungal infections. It can be diagnosed using serum-opsonized E.coli as a stimulus in dihydrorhodamine (DHR) assay. Patients with CYBC1/Eros deficiency, a new and rare form of CGD, present as loss of respiratory burst and gp91 phox expression in phagocytes. Neutrophils from patients with CGD are deficient in neutrophil extracellular traps (NETosis), autophagy, and apoptosis. The hyper-activation of NF-ĸB and inflammasome in CGD phagocytes also lead to long-lasting production of pro-inflammatory cytokines and inflammatory manifestations, such as granuloma formation and inflammatory bowel disease-like colitis. Patients with CGD and X-linked female carriers also have a higher incidence of autoimmune diseases. The implementation of antimicrobial, anti-fungal, and interferon-γ prophylaxis has greatly improved overall survival. Residual NADPH oxidase activity is significantly associated with disease severity and the chance of survival of the patient. New therapeutic approaches using immunomodulators for CGD-related inflammatory manifestations are under investigation, including pioglitazone, tamoxifen, and rapamycin. Hematopoietic stem cell transplantation (HSCT) is the curative treatment. Outcomes of HSCT have improved substantially over the last decade with overall survival more than 84-90%, but there are debates about designing optimal conditioning protocols using myeloablative or reduced-intensity regimens. The gene therapy for X-linked CGD using hematopoietic stem and progenitor cells transduced ex vivo by lentiviral vector encoding the human gp91phox gene demonstrated persistence of adequate oxidase-positive neutrophils in a small number of patients. Gene therapy using genome-editing technology such as CRISPR/Cas9 nucleases is a promising approach for patients with CGD in the future.

Overview

Integrity signals

Registry

Crossref · 10.1007/s12016-020-08800-x

Cites

101 of 101 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 101 references

Cited by

See all 213

Metadata

Authors
Yu, H.-H., Yang, Y.-H., & Chiang, B.-L.
Affiliations
  • National Taiwan University (TW)
  • National Taiwan University Hospital (TW)
Corresponding author
Chiang, Bor-Luen
Venue
Clinical Reviews in Allergy & Immunology
Published
2020-06-10
Volume
61
Issue
2
Pages
101-113
ISSN
  • 1080-0549 (ISSN-L)
  • 1559-0267
OpenAlex
W3033126525
Cited by
197
References
102
Citations by year
2026: 29 · 2025: 45 · 2024: 22 · 2023: 47 · 2022: 26 · 2021: 25 · 2020: 3
FWCI
2.47
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Clinical Reviews in Allergy & Immunology (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Taiwan University Hospital (109-A152)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
  • Health Sciences › Medicine › Hematology › Blood disorders and treatments
Keywords
chronic granulomatous disease, NADPH oxidase deficiency, neutrophil extracellular traps, autophagy, apoptosis, NF-κB activation, inflammasome, granuloma formation, autoimmune disease, hematopoietic stem cell transplantation, gene therapy, lentiviral vectors, CRISPR/Cas9 genome editing, immunomodulators
MeSH terms
Animals, Granulomatous Disease, Chronic, Humans, Neutrophils, Genetic Therapy, NADPH Oxidases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chronic Granulomatous Disease: a Comprehensive Review. https://app.cochat.ai/papers/10.1007/s12016-020-08800-x
The paper
Yu, H.-H., Yang, Y.-H., & Chiang, B.-L. (2021). Chronic Granulomatous Disease: a Comprehensive Review. Clinical Reviews in Allergy & Immunology. https://doi.org/10.1007/s12016-020-08800-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.